January 29, 2021

Wow or Yeow?! FDA Outlook for 2021 and Beyond

Presented by Kinexum



Tim Franson, principal at Faegre Drinker Consulting, joins a panel of drug development regulatory experts to discuss the unprecedented and tumultuous nature of 2020, focusing on the simultaneous challenges of a once-in-a-century global pandemic, the resulting socioeconomic fallout, and political polarization regarding policy responses to the pandemic, civil rights protests and presidential elections, all of which may impact development and care processes. The Food and Drug Administration (FDA) has responded to these pressures with varying degrees of success and now faces an incoming administration that in many ways could not contrast more sharply with its predecessor.

Additional event speakers include:

  • Frank Sasinowski, director at Hyman, Phelps & McNamara
  • Steven Grossman, president of HPS Group
  • David Fox, partner at Hogan Lovells
  • Zan Fleming, M.D., executive chairman of Kinexum

Related Legal Services

Related Policy, Advocacy, and Consulting Services

Related Industries

Related Topics

The Faegre Baker Daniels website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Baker Daniels' cookies information for more details.